Skip to search formSkip to main contentSkip to account menu

CGP 19984

Known as: CGP-19984, CGP-19984A 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Short‐term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: Efficacy of the…
A model system has been developed that permits short‐term culture of rat R3327 prostate adenocarcinoma epithelial cells on a… 
1988
1988
Effects of the thiazolidinedione derivative CGP 19984 on growth and endocrine function of the Mtt‐W10 transplantable mammosmatotoropic pituitary tumor in female rats
The thiazolidinedione derivative CGP 19984 has previously been shown to suppress the growth of hormone‐dependent mammary and… 
1988
1988
EFFECTS OF THE THIAZOLIDINEDIONE DERIVATIVE CGP 19984 ON GROWTH MAMMOSOMATOTROPIC PITUITARY TUMOR IN FEMALE RATS
The thiazolidinedione derivative CGP 19984 has previously been shown to suppress the growth of hormone-dependent mammary and… 
1986
1986
Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
The antitumor efficacy and the hormonal effects of the thiazolidine-dione derivative (sodium methyl((-3-methyl-2- ([5-methyl-3-(2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)